Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych MEQs / SAQsFoundations — psychiatric genetics and epigenetics

Psych MEQs / SAQs · Foundations — psychiatric genetics and epigenetics

Psychiatric genetics and epigenetics — family counselling MEQ

FRANZCP/MRCPsych-style MEQ integrating heritability concepts, family counselling, GWAS/PRS limits, 22q11.2DS, and ethics.

20 marks20 min
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
You are the psychiatry registrar reviewing a 19-year-old with first-episode schizophrenia. His mother asks three questions: (1) 'Is this 80% genetic so treatment is pointless?' (2) 'What is the chance his younger sister will get the same illness?' (3) 'Should the whole family buy an online polygenic risk test?' Separately, the medical team notes repaired tetralogy of Fallot, intermittent hypocalcaemia, and nasal speech. (i) Define heritability and correct the mother's first misunderstanding with twin-study evidence. (ii) Outline how you would structure empiric recurrence-risk counselling for the sister. (iii) Explain what GWAS and polygenic scores add — and their current clinical limits. (iv) Interpret the medical clues and outline genetic investigation and care principles if 22q11.2 deletion is confirmed. (v) State three ethical principles guiding psychiatric genetic testing and counselling. (20 marks)

Model answer

Reveal model answer

(i) Heritability vs fatalism. Heritability is the proportion of phenotypic variance in a population attributable to genetic differences, not the percentage of this young man's illness that is genetic and not a statement that outcomes are fixed.[1] Twin meta-analysis estimates schizophrenia liability heritability around 80%, and Danish registry twins show similar high heritability with incomplete MZ concordance — proving environment and other non-genetic factors matter.[1][2] Therefore evidence-based antipsychotic, psychosocial, and educational interventions remain essential; high heritability does not equal therapeutic nihilism.

(ii) Sister counselling structure. Take a three-generation pedigree; explain multifactorial (polygenic + environment) risk; give empiric absolute risks for siblings (elevated above ~1% population risk, classically taught first-degree risks on the order of ~10% depending on source and definition — state uncertainty and avoid false precision); emphasise that most siblings remain well; offer support, early-help education (not scare campaigns); document and offer written summary; involve clinical genetics if a high-impact variant is later found.[1][2]

(iii) GWAS/PRS. GWAS have identified many common risk loci (e.g. PGC 108 loci landmark; larger subsequent maps), supporting a polygenic model.[3] Common polygenic scores capture part of shared risk with bipolar disorder historically shown by the ISC.[4] Current clinical discriminative ability of PRS in the general population is limited; they are not routine diagnostic tests, transfer poorly across ancestries when misapplied, and should not drive commercial "yes/no" family testing.[5]

(iv) Syndromic clues → 22q11.2DS. Cardiac conotruncal defect, hypocalcaemia, and palatal/speech features raise pretest probability of 22q11.2 deletion — a CNV with high relative risk for psychosis and multisystem morbidity.[6][7][8] Action: liaise clinical genetics for appropriate CNV testing; if confirmed, multidisciplinary care (psychiatry, cardiology, endocrinology/calcium, immunology, developmental supports) per 22q guidelines; counsel that psychiatric treatment of psychosis still follows standard principles while medical comorbidities are actively managed.[6][7]

(v) Ethics. (1) Autonomy / non-directiveness in reproductive and testing decisions. (2) Privacy of genetic information and careful handling of relative implications. (3) Justice / non-maleficence — avoid ancestry-biased PRS harm, stigma, and coercive testing; ensure informed consent including limits of utility.[5]

Common errors

Equating 80% heritability with 80% personal risk; dismissing treatment; promising a single gene test; ordering DTC PRS as diagnosis; missing medical red flags for 22q11; inventing exact statute numbers; genetic essentialism about violence or worth.[1][5][7]

References

  1. [1]Sullivan PF, Kendler KS, Neale MC Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies Arch Gen Psychiatry, 2003.PMID 14662550
  2. [2]Hilker R, Helenius D, Fagerlund B, et al. Heritability of Schizophrenia and Schizophrenia Spectrum Based on the Nationwide Danish Twin Register Biol Psychiatry, 2018.PMID 28987712
  3. [3]Schizophrenia Working Group of the Psychiatric Genomics Consortium Biological insights from 108 schizophrenia-associated genetic loci Nature, 2014.PMID 25056061
  4. [4]International Schizophrenia Consortium Common polygenic variation contributes to risk of schizophrenia and bipolar disorder Nature, 2009.PMID 19571811
  5. [5]Lewis CM, Vassos E Polygenic risk scores: from research tools to clinical instruments Genome Med, 2020.PMID 32423490
  6. [6]Bassett AS, McDonald-McGinn DM, Devriendt K, et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome J Pediatr, 2011.PMID 21570089
  7. [7]McDonald-McGinn DM, Sullivan KE, Marino B, et al. 22q11.2 deletion syndrome Nat Rev Dis Primers, 2015.PMID 27189754
  8. [8]Marshall CR, Howrigan DP, Merico D, et al. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects Nat Genet, 2017.PMID 27869829